Literature DB >> 28349660

Intra-prelimbic cortical inhibition of striatal-enriched tyrosine phosphatase suppresses cocaine seeking in rats.

Ben M Siemsen1, Paul J Lombroso2, Jacqueline F McGinty1.   

Abstract

Cocaine self-administration in <span class="Species">rats results in dysfunctional neuroadaptations in the prelimbic (PrL) cortex during early abstinence. Central to these adaptations is decreased phospho-extracellular signal-regulated kinase (p-ERK), which plays a key role in cocaine seeking. Normalizing ERK phosphorylation in the PrL cortex immediately after cocaine self-administration decreases subsequent cocaine seeking. The disturbance in ERK phosphorylation is accompanied by decreased phosphorylation of striatal-enriched protein tyrosine phosphatase (STEP), indicating increased STEP activity. STEP is a well-recognized ERK phosphatase but whether STEP activation during early abstinence mediates the decrease in p-ERK and is involved in relapse is unknown. Here, we show that a single intra-PrL cortical microinfusion of the selective STEP inhibitor, TC-2153, immediately after self-administration suppressed post-abstinence context-induced relapse under extinction conditions and cue-induced reinstatement, but not cocaine prime-induced drug seeking or sucrose seeking. Moreover, an intra-PrL cortical TC-2153 microinfusion immediately after self-administration prevented the cocaine-induced decrease in p-ERK within the PrL cortex during early abstinence. Interestingly, a systemic TC-2153 injection at the same timepoint failed to suppress post-abstinence context-induced relapse or cue-induced reinstatement, but did suppress cocaine prime-induced reinstatement. These data indicate that the STEP-induced ERK dephosphorylation in the PrL cortex during early abstinence is a critical neuroadaptation that promotes relapse to cocaine seeking and that systemic versus intra-PrL cortical inhibition of STEP during early abstinence differentially suppresses cocaine seeking.
© 2017 Society for the Study of Addiction.

Entities:  

Keywords:  STEP; TC-2153; cocaine; extracellular signal-regulated kinase; prelimbic cortex; self-administration

Mesh:

Substances:

Year:  2017        PMID: 28349660      PMCID: PMC5617773          DOI: 10.1111/adb.12504

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  30 in total

1.  Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP).

Authors:  Steven P Braithwaite; Michael Adkisson; John Leung; Adrian Nava; Brett Masterson; Roman Urfer; Donna Oksenberg; Karoly Nikolich
Journal:  Eur J Neurosci       Date:  2006-06       Impact factor: 3.386

2.  A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures.

Authors:  P J Lombroso; J R Naegele; E Sharma; M Lerner
Journal:  J Neurosci       Date:  1993-07       Impact factor: 6.167

3.  The suppressive effect of an intra-prefrontal cortical infusion of BDNF on cocaine-seeking is Trk receptor and extracellular signal-regulated protein kinase mitogen-activated protein kinase dependent.

Authors:  Timothy W Whitfield; Xiangdang Shi; Wei-Lun Sun; Jacqueline F McGinty
Journal:  J Neurosci       Date:  2011-01-19       Impact factor: 6.167

4.  Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP.

Authors:  Jian Xu; Pradeep Kurup; Yongfang Zhang; Susan M Goebel-Goody; Peter H Wu; Ammar H Hawasli; Matthew L Baum; James A Bibb; Paul J Lombroso
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

5.  Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons.

Authors:  Anton Ivanov; Christophe Pellegrino; Sylvain Rama; Iryna Dumalska; Yuriy Salyha; Yehezkel Ben-Ari; Igor Medina
Journal:  J Physiol       Date:  2006-05-01       Impact factor: 5.182

6.  The effect of active and passive intravenous cocaine administration on the extracellular signal-regulated kinase (ERK) activity in the rat brain.

Authors:  Joanna Miszkiel; Jan Detka; Joanna Cholewa; Małgorzata Frankowska; Ewa Nowak; Bogusława Budziszewska; Edmund Przegaliński; Małgorzata Filip
Journal:  Pharmacol Rep       Date:  2014-03-05       Impact factor: 3.024

7.  Inhibition of the tyrosine phosphatase STEP61 restores BDNF expression and reverses motor and cognitive deficits in phencyclidine-treated mice.

Authors:  Jian Xu; Pradeep Kurup; Tyler D Baguley; Ethan Foscue; Jonathan A Ellman; Angus C Nairn; Paul J Lombroso
Journal:  Cell Mol Life Sci       Date:  2015-10-08       Impact factor: 9.261

8.  Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors.

Authors:  F Léveillé; F El Gaamouch; E Gouix; M Lecocq; D Lobner; O Nicole; A Buisson
Journal:  FASEB J       Date:  2008-08-18       Impact factor: 5.191

9.  STEP activation by Gαq coupled GPCRs opposes Src regulation of NMDA receptors containing the GluN2A subunit.

Authors:  Meng Tian; Jian Xu; Gang Lei; Paul J Lombroso; Michael F Jackson; John F MacDonald
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

10.  Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models.

Authors:  J Xu; B J Hartley; P Kurup; A Phillips; A Topol; M Xu; C Ononenyi; E Foscue; S-M Ho; T D Baguley; N Carty; C S Barros; U Müller; S Gupta; P Gochman; J Rapoport; J A Ellman; C Pittenger; B Aronow; A C Nairn; M W Nestor; P J Lombroso; K J Brennand
Journal:  Mol Psychiatry       Date:  2016-10-18       Impact factor: 13.437

View more
  7 in total

1.  Effects of Methamphetamine Self-Administration and Extinction on Astrocyte Structure and Function in the Nucleus Accumbens Core.

Authors:  B M Siemsen; C M Reichel; K C Leong; C Garcia-Keller; C D Gipson; S Spencer; J A McFaddin; K N Hooker; P W Kalivas; M D Scofield
Journal:  Neuroscience       Date:  2019-03-26       Impact factor: 3.590

2.  Biphasic effect of abstinence duration following cocaine self-administration on spine morphology and plasticity-related proteins in prelimbic cortical neurons projecting to the nucleus accumbens core.

Authors:  B M Siemsen; G Giannotti; J A McFaddin; M D Scofield; Jacqueline F McGinty
Journal:  Brain Struct Funct       Date:  2018-11-29       Impact factor: 3.270

3.  Chronic alcohol disrupts hypothalamic responses to stress by modifying CRF and NMDA receptor function.

Authors:  Vincent N Marty; Yatendra Mulpuri; Joseph J Munier; Igor Spigelman
Journal:  Neuropharmacology       Date:  2020-02-12       Impact factor: 5.250

4.  Role of Src Family Kinases in BDNF-Mediated Suppression of Cocaine-Seeking and Prevention of Cocaine-Induced ERK, GluN2A, and GluN2B Dephosphorylation in the Prelimbic Cortex.

Authors:  Sarah M Barry; Jacqueline F McGinty
Journal:  Neuropsychopharmacology       Date:  2017-06-06       Impact factor: 7.853

5.  Amperometric measurements of cocaine cue and novel context-evoked glutamate and nitric oxide release in the nucleus accumbens core.

Authors:  Benjamin M Siemsen; John A McFaddin; Keiana Haigh; Ashley G Brock; Mary Nan Leath; Kaylee N Hooker; Lilly K McGonegal; Michael D Scofield
Journal:  J Neurochem       Date:  2020-02-03       Impact factor: 5.372

6.  Insight into the Role of the STriatal-Enriched Protein Tyrosine Phosphatase (STEP) in A2A Receptor-Mediated Effects in the Central Nervous System.

Authors:  Maria Rosaria Domenici; Cinzia Mallozzi; Rita Pepponi; Ida Casella; Valentina Chiodi; Antonella Ferrante; Patrizia Popoli
Journal:  Front Pharmacol       Date:  2021-04-19       Impact factor: 5.810

7.  A Subset of Nucleus Accumbens Neurons Receiving Dense and Functional Prelimbic Cortical Input Are Required for Cocaine Seeking.

Authors:  Benjamin M Siemsen; Sarah M Barry; Kelsey M Vollmer; Lisa M Green; Ashley G Brock; Annaka M Westphal; Raven A King; Derek M DeVries; James M Otis; Christopher W Cowan; Michael D Scofield
Journal:  Front Cell Neurosci       Date:  2022-02-24       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.